Search Results for:

• HASTINGS CENTER NEWS

  Although the U.S. has the highest health care prices in the world, the specific mechanisms commonly used by other countries to set and update prices are often overlooked, with a tendency to favor strategies such as reducing the use of fee-for-service reimbursement. Many U.S. health policymakers recognize that fee-for-service models incentivize physicians and health systems… Read more

  Share:

  Read more

  HASTINGS CENTER NEWS

  

  Hastings Center Scholar on How Some Countries Control Health Spending

  Read more

• HASTINGS CENTER NEWS

  The Compassionate Use Advisory Committee, headed by Hastings Center Fellow Arthur Caplan, of NYU Langone, received the Reagan-Udall Foundation for the Food and Drug Administration’s Innovation Award. The committee was recognized for transforming how expanded access requests, also known as compassionate use requests, are granted by drug developers.

  Share:

  Read more

  HASTINGS CENTER NEWS

  

  Hastings Center Scholars Respond to Prison Sentence of Researcher Who Created First Gene-Edited Babies

  Read more

• HASTINGS CENTER NEWS

  The Compassionate Use Advisory Committee, headed by Hastings Center Fellow Arthur Caplan, of NYU Langone, received the Reagan-Udall Foundation for the Food and Drug Administration’s Innovation Award. The committee was recognized for transforming how expanded access requests, also known as compassionate use requests, are granted by drug developers.

  Share:

  Read more

  HASTINGS CENTER NEWS

  

  Helping Seriously Ill Patients Access “Last Resort” Medicines

  Read more

• HASTINGS CENTER NEWS

  The Hastings Center is pleased to announce the winner of the inaugural David Roscoe Award for an Early-Career Essay on Science, Ethics, and Society. “Recruitment and Trial-Finding Apps: Time for Rules of the Road,” by Stephanie R. Morain and Emily A. Largent, published in May in the Journal of the National Cancer Institute, explores the… Read more

  Share:

  Read more

  HASTINGS CENTER NEWS

  

  Award-Winning Essay: How Can Mobile Apps Improve Clinical Trials and Safeguard Participants?

  Read more

• HASTINGS CENTER NEWS

  The American Pharmacists Association Foundation recognized Hastings Center's Rosemary Gibson with a 2019 Pinnacle Award for career achievement on Monday, September 16.  Gibson, a senior advisor at The Hastings Center, is the author most recently of China Rx: Exposing the Risks of America's Dependence on China for Medicine. The book chronicles the shift to China as a… Read more

  Share:

  Read more

  HASTINGS CENTER NEWS

  

  Hastings Center’s Rosemary Gibson Honored for Enhancing Health Care Quality

  Read more

• BIOETHICS FORUM ESSAY

  In 2012, I coauthored a case report about the successful use of dietary supplements in treating a case of male infertility in the American Family Physician. Before it was published, I was surprised to receive a communication asking me to disclose the fact that I had written a textbook on dietary supplements. It had not… Read more

  Share:

  Read more

  BIOETHICS FORUM ESSAY

  

  Let the Sun Shine into the Medical Ivory Tower

  Read more

• BIOETHICS FORUM ESSAY

  Addyi, a drug that made a splash when it was approved in the summer of 2015 as the first “female Viagra,” is back. Its rise, fall, and rise again is an example of shrewd pharmaceutical marketing and the potential dangers it can pose to patients. Addyi, or flibanserin, is a purported aphrodisiac that failed twice… Read more

  Share:

  Read more

  BIOETHICS FORUM ESSAY

  

  Addyi Rises Again

  Read more

• BIOETHICS FORUM ESSAY

  In February, Senator Claire McCaskill (D-Missouri) published a report that revealed the unsettling relationship between opioid manufacturers and pain advocacy groups. Focusing on five opioid manufacturers, Purdue, Janssen, Depomed, Insys, and Mylan, the report found that manufacturers contributed $9 million to 14 pain advocacy groups within five years. The U.S. Pain Foundation received the most… Read more

  Share:

  Read more

  BIOETHICS FORUM ESSAY

  

  Fentanyl at Your Door: Who are Pain Groups Advocating For?

  Read more

• BIOETHICS FORUM ESSAY

  In 1971, the United Nations passed a resolution prohibiting its member nations from advertising psychotropic drugs to the general public. More than 40 years later, this resolution has done little to halt pharmaceutical companies from marketing stimulants as treatments for attention deficit-hyperactivity disorder. The means by which, and the ethical dilemmas involved when, pharmaceutical companies… Read more

  Share:

  Read more

  BIOETHICS FORUM ESSAY

  

  Masked Marketing: Pharmaceutical Company Funding of ADHD Patient Advocacy Groups

  Read more

• BIOETHICS FORUM ESSAY

  Three years ago, a small pharmaceutical company with a big agenda created a fake feminist group so that they could get a bad drug approved by the Food and Drug Administration. The story of how this happened is a case study in how industry affects medical discourse, the subject of a PharmedOut conference that will… Read more

  Share:

  Read more

  BIOETHICS FORUM ESSAY

  

  The Score is Even

  Read more